Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles Tackney is active.

Publication


Featured researches published by Charles Tackney.


Journal of Biotechnology | 1994

High-level expression of a biologically active human interleukin-6 mutein

Susan M. Skelly; Charles Tackney; Daniel J. Hicklin; Theresa Tamkins; Neil I. Goldstein; Harlan Waksal; Shlomo Dagan

We have constructed two different muteins of interleukin-6 (IL-6) which were expressed in Escherichia coli. Both muteins lack the first 22 N-terminal amino acids of native IL-6 and lack one or the other of the two naturally occurring pairs of cysteines at either position 45 and 51 or position 74 and 84 of IL-6. We found that there was a dramatic increase in the level of IL-6 produced from each mutein clone, compared to the level produced by the wild-type IL-6 clone. We also observed that the yield of soluble and properly refolded mutein IL-6 was highest when the cysteines at position 74 and 84 were left intact. The mutein IL-6 with cysteines at position 74 and 84 was as active as wild-type IL-6 and a lower concentration of the mutein IL-6 was required to reach maximal activity, compared to wild-type IL-6. The mutein IL-6 with cysteines at position 45 and 51 had a much reduced biological activity.


Protein Expression and Purification | 1992

High-level expression and production of recombinant human interleukin-6 analogs

Shlomo Dagan; Charles Tackney; Susan M. Skelly

We have constructed and analyzed different mutant forms of interleukin-6 (IL-6) expressed in Escherichia coli that can be divided into two groups. The first group contains four full-length IL-6 molecules that differ in the presence of cysteine residues involved in disulfide bridges. The second group contains 22 N-terminal amino acid deletions in addition to the differences in the cysteine residues. The different IL-6 muteins were extracted and their expression levels and solubility were compared. We found that the production levels of IL-6 can be dramatically improved by deleting the first 22 N-terminal amino acids of the molecule. We have also found that the production of IL-6 containing the four cysteine residues is lower than the production of the mutant molecules that lack one or both pairs of cysteines. The yield of soluble and properly refolded IL-6 was the highest when the disulfide bond between the cysteines at positions 74 and 84 was present in the mutein form, which also lacked the 22 N-terminal amino acids.


Archive | 1992

Recombinant hybrid porin epitopes

Neil I. Goldstein; Charles Tackney


Archive | 1991

PDGF-B fusion protein, vectors, and host cells for use in production thereof

Charles Tackney; Jurgen Hoppe; Wolfram Eichner; Herbert Weich


Archive | 1989

Recombinant pdgf and methods for production

Charles Tackney; Jürgen Hoppe; Wolfram Eichner; Herbert Weich


Archive | 1994

Stabilized hepatitis B e antigen suitable for immunoassays

Daniel J. Hicklin; Charles Tackney; Harlan Waksal


Hybridoma | 1991

Isolation of a Monoclonal Antibody to the TrpE Protein and Its Use for the Purification of Recombinant Fusion Proteins

Fay Nurse; Shlomo Dagan; Charles Tackney; Neil I. Goldstein


Archive | 1992

Muteines d'il-6 depourvues de cysteine_____________

Susan M. Skelly; Charles Tackney; John N. Snouwaert; Dana M. Fowlkes


Archive | 1992

Cysteinfreie il-6 mutanten Cysteine-free IL-6 mutant

Susan M. Skelly; Charles Tackney; John N. Snouwaert; Dana M. Fowlkes


Archive | 1992

Cysteine-il-6 mutant

Susan M. Skelly; Charles Tackney; John N. Snouwaert; Dana M. Fowlkes

Collaboration


Dive into the Charles Tackney's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John N. Snouwaert

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge